[Pharmacological and pharmacogenetic study of two immunomodulators: azathioprine and 6-mercaptopurine. Strategies for preventing complications].

Gastroenterol Clin Biol

Service de biochimie, toxicologie et pharmacologie cliniques, hôpital d'instruction-des-armées-Begin, 69, avenue de Paris, 94160 Saint-Mandé, France.

Published: March 2009

Thiopurines are frequently used in gastroenterology for Crohn's disease or hemorrhagic rectocolitis. Their metabolism is regulated by a particular enzyme, thiopurine S-methyltransferase or TPMT. There are three ways to evaluate the effectiveness and the risk of side effects associated with this treatment. TPMT activity measurement or genotyping are recommended to decide for treatment, while metabolites determination is a used as marker of monitoring. Phenotypic approach (TPMT activity measurement or metabolites determination) requires delicate techniques and interindividual variations make the interpretation difficult. Genotyping is easier to interpret but cannot exclude some risk of side effects.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gcb.2008.10.014DOI Listing

Publication Analysis

Top Keywords

risk side
8
side effects
8
tpmt activity
8
activity measurement
8
metabolites determination
8
[pharmacological pharmacogenetic
4
pharmacogenetic study
4
study immunomodulators
4
immunomodulators azathioprine
4
azathioprine 6-mercaptopurine
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!